Optibiotix Health Share Discussion Threads

[pj 1] 16/3/2018 10:49

elric-I'd also add that generally Market dynamics seem to have altered since 3/4 years ago. Most of my profits previously have come from Zulu-esq type stocks. Its now very hard to find Zulu stocks which fit all the criteria. However, what I have noticed is that 4 years ago the Market would ''price in'' forward 2 years forecast growth. Now its pricing in 1 years forecast and often less i.e. current year (generally there are always exceptions such as FEVR/OCDO/PURP). Maybe an indicator the Bull market is nearing the start of the end of the run?

Or maybe an indicator it has much further to run yet?

[elrico] 16/3/2018 10:31

PJ - Fair points. IMHO OPTI is a little more complicated company to understand than the likes of FEVR (I accept we are not comparing apples with pears). OPTI has hurdles such as understanding the new humanbiome science, new products using the new science, business model and more importantly, how is it monitising the IP and of course cash visibility. Most of us have grasped all but cash visibility...or like to think we have (I include myself), until the market see's the cash and or household names using, LP-LDL, SlimBiome, SweetBiotix, OptiBiotic, we are in limbo. The market seems incapable of data mining what existing partnerships can bring to the table in terms of household names and cash flow which almost certainly drops to the bottom-line. SOH has penciled in breakeven in 2018. IMHO this will be the catalyst for beating market expectation and the development of a pattern of over achieving revenue expectations for several years. If you are invested at this stage, then significant rewards will be our reward for patience, foresight in finding a new company in an exciting new area of science in the food and beverage industry for both human and animal feed-stock. It isn't easy trusting your research when the chart appears to be screaming fool, can you not see? Times like this you need to trust your research, BOD and become a contrarian, something which seems unfashionable. Not long now folks....honest! :)

[pj 1] 16/3/2018 09:38

Septimus. There is much more to it than that. FEVR generates cash, has strong published growth opportunities and regularly beats Market expectations. It therefore commands a very high p/e until the growth stalls but that could be 3/ 5 years away yet. No doubt at some point in the future it will be a short. What people also forget is that it has a different taste to schwepps. One day the ''fad'' will be copied, as it is being done now, and even schwepps is changing its offerings. FEVR has no moat though.

Hopefully OPTI at some point will reflect the same market sentiment as FEVR is awarded NOW, but FEVR is not without good reason.

[septimus quaid] 16/3/2018 09:25

The markets don't half pick their heroes and villains.

OPTI can do no right, Fever-Tree, a fad, fizzy pop manufacturer, can do no wrong.

[loungeact] 16/3/2018 09:03

£1 soon..

[jimmylufc] 16/3/2018 09:00

Thanks Mouse - that's good press for OPTI - but no affect on share price - if any other share got that kind of publicity they would fly !

[mouse20] 16/3/2018 08:54

Cutting-edge weight loss technology developed in the UK is going to be used to combat the high sugar and calorie content of cereal products in the US. The SlimBiome weight loss technology, developed by OptiBiotix Health, is a patented functional ingredient which helps people to consistently manage weight loss by reducing food intake, without the usual food cravings

[vanduke] 16/3/2018 08:41

44p soon..

[zebbo] 15/3/2018 18:54

Hey guys, yep behind the curve :~/. Had to crack on with my day job...lol

[loungeact] 15/3/2018 18:16

Poor Michaelmouse

[monkeywench1] 15/3/2018 17:26

Are the Rampers fools or clever?

[judijudi] 15/3/2018 17:25

Agree
But the fools are far outnumbering the clever ones. And have been for ages on most days

[trotterstrading] 15/3/2018 17:19

Fools selling their golden tickets for a few bob

[primal123] 15/3/2018 16:44

So disappointing to fall on virtually no volume! When there are buyers it takes loads of buys to move it up!

[elrico] 15/3/2018 15:57

Thanks TT.

I nicked some of you post 33271 for a tweet ;)

[elrico] 15/3/2018 15:56

Zebbo - Be mindful Riccardo Lowi is not a true analyst, according to TW. However, his specialism is "life science." DYOR, etc ;)

[scotty1] 15/3/2018 15:28

Posted a couple of days ago zebbo,do keep up 😀

[monkeywench1] 15/3/2018 15:25

More ramping but no move on the share price

[zebbo] 15/3/2018 15:23

Analyst Update on Opti

[zebbo] 15/3/2018 15:15

Elrico, do you have the text, my PC dont like that link

[elrico] 15/3/2018 15:14

Trotters - Do you have a link to the podcast? Cheers.

[riskybusiness1] 15/3/2018 15:07

Anyone that watched the SOH interview last week would have heard that both of last weeks deals should earn Opti between £750k - £1.25m per year as well as Galenicum who will be launching within the next few months. Also Opti has over a handful of deals already in progress in the region of £250k to £500k. All with an £80-£90k per month operating cost with the majority of this being R&D and Patent related. Some serious growth to come here when the numbers do come through. The routes to market being developed have significant accumulative earning potential.

[elrico] 15/3/2018 14:43

Cheap shot from TW. You really couldn't make this up!

[judijudi] 15/3/2018 14:43

JH,
I have no idea about chartists thoughts and I'm not interested in what they have to say
But on the rest of your post I do tend to agree
That's why I'm an investor in Opti and not a trader